These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 2553248

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Expression of protein-associated DNA damage in the alkaline elution assay in the absence of enzymatic deproteinization.
    Gewirtz DA, Ellis AL, Randolph JK, Yanovich S, Swerdlow PS, Povirk LF, Yalowich JC.
    Cancer Commun; 1989; 1(3):175-80. PubMed ID: 2561738
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide.
    Long BH, Musial ST, Brattain MG.
    Cancer Res; 1986 Aug; 46(8):3809-16. PubMed ID: 3015377
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Formation of topoisomerase II alpha complexes with nascent DNA is related to VM-26-induced cytotoxicity.
    Qiu J, Catapano CV, Fernandes DJ.
    Biochemistry; 1996 Dec 17; 35(50):16354-60. PubMed ID: 8973211
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Arrest of replication fork progression at sites of topoisomerase II-mediated DNA cleavage in human leukemia CEM cells incubated with VM-26.
    Catapano CV, Carbone GM, Pisani F, Qiu J, Fernandes DJ.
    Biochemistry; 1997 May 13; 36(19):5739-48. PubMed ID: 9153414
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Identification of DNA topoisomerase II as an intracellular target of antitumor epipodophyllotoxins in simian virus 40-infected monkey cells.
    Yang L, Rowe TC, Liu LF.
    Cancer Res; 1985 Nov 13; 45(11 Pt 2):5872-6. PubMed ID: 2996763
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Targeting the cytotoxicity of topoisomerase II-directed epipodophyllotoxins to tumor cells in acidic environments.
    Jensen PB, Sørensen BS, Sehested M, Grue P, Demant EJ, Hansen HH.
    Cancer Res; 1994 Jun 01; 54(11):2959-63. PubMed ID: 8187081
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Studies of topoisomerase-specific antitumor drugs in human lymphocytes using rabbit antisera against recombinant human topoisomerase II polypeptide.
    Hwang JL, Shyy SH, Chen AY, Juan CC, Whang-Peng J.
    Cancer Res; 1989 Feb 15; 49(4):958-62. PubMed ID: 2536295
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Selective inhibition of topoisomerase II by ICRF-193 does not support a role for topoisomerase II activity in the fragmentation of chromatin during apoptosis of human leukemia cells.
    Beere HM, Chresta CM, Hickman JA.
    Mol Pharmacol; 1996 May 15; 49(5):842-51. PubMed ID: 8622634
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.